Long-Term Safety and Efficacy of Certolizumab Pegol in Combination with Methotrexate in the Treatment of Rheumatoid Arthritis: 5-Year Results from a 52-Week Randomized Controlled Trial and Open-Label Extension Study
Author(s):
Keystone, E.; Landewe, R.; Vollenhoven, R. van; Combe, B.; Strand, V.; Mease, P.; Shaughnessy, L.; VanLunen, B.; Heijde, D. van der
Published
2014
Publication type
Article / Letter to editor
Date issued
2014-07-31
Language
English
Is part of
Journal of Rheumatology (2014), Vol. 41, no. 7, p. 1455-1456
